Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity

International Journal of Oncology

Volumn 29, Issue 5, 2006, Pages 1207-1213

  Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

Author keywords

Apoptosis; Bcl 2; Caspase 3; hTERT; Sodium butyrate; Telomerase

Indexed keywords

BUTYRIC ACID DERIVATIVE; CASPASE 3; FAS ANTIGEN; FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; TELOMERASE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HUMAN; LEUKEMIA; METABOLISM; TUMOR CELL LINE;

ANTIGENS, CD95; APOPTOSIS; BUTYRATES; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LEUKEMIA; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE;

EID: 37049034838     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.5.1207     Document Type: Article

References (31)

1. Schultz DR and Harrington WJ Jr: Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32: 345-369, 2003.
2. Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001.
3. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 6: 383-424, 1999.
4. Hahn WC and Meyerson M: Telomerase activation, cellular immortalization and cancer. Ann Med 33: 123-129, 2001.
5. Oulton R and Harrington L: Telomeres, telomerase, and cancer: life on the edge of genomic stability. Curr Opin Oncol 12: 74-81, 2000.
6. Odago FO and Gerson SL: Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy. Trends Pharmacol Sci 24: 328-331, 2003.
7. Autexier C and Greider CW: Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 21: 387-391, 1996.
8. Cummings JH: Short chain fatty acids in the human colon. Gut 22: 763-779, 1981.
9. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65-82, 1982. (Pubitemid 12118742)
10. Candido EP, Reeves R and Davie JR: Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14: 105-113, 1978. (Pubitemid 8340438)
11. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, Meng S and Hodin RA: The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 289: G696-G703, 2005. (Pubitemid 41377176)
12. Chopin V, Toillon RA, Jouy N and Le Bourhis X: P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 23: 21-29, 2004.
13. Wang YF, Chen NS, Chung YP, Chang LH, Chiou YH and Chen CY: Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1/WAF1) induction. Mol Cell Biochem 14: 1-9, 2006.
14. Madigan MC, Chaudhri G, Penfold PL and Conway RM: Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines. Oncol Res 11: 331-337, 1999.
15. Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L and Marcelli M: Overexpression of BCL-X (L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 61: 1699-1706, 2001.
16. Tsai LC, Hung MW, Chang GG and Chang TC: Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Anticancer Res 20: 2441-2448, 2000.
17. Litvak DA, Hwang KO, Evers BM and Townsend CM: Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res 20: 779-784, 2000.
18. Hara I, Miyake H, Hara S, Arakawa S and Kamidono S: Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17: 1213-1218, 2000.
19. Hernandez A, Thomas R, Smith F, Sandberg J, Kim S, Chung DH and Evers BM: Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 130: 265-272, 2001. (Pubitemid 32721679)
20. Decaudin D, Marzo I, Brenner C and Kroemer G: Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy. Int J Oncol 12: 141-152, 1998.
21. Stennicke HR and Salvesen GS: Properties of the caspases. Biochim Biophys Acta 1387: 17-31, 1998.
22. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
23. Roy N, Deveraux QL, Takahashi R, Salvesen GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925, 1997.
24. Nagata S and Golstein P: The Fas death factor. Science 267: 1449-1456, 1996.
25. Jiang C, Yang YF and Cheng SH: Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 4: 33-39, 2004.
26. Mandal M and Kumar R: Bcl-2 modulates telomerase activity. J Biol Chem 72: 14183-14187, 1997.
27. Fu W, Begley JG, Killen MW and Mattson MP: Anti-apoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 274: 7264-7271, 1999.
28. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H and Inoue M: Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 80: 804-809, 1990.
29. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H and Inoue M: Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28: 669-677, 2000.
30. Drissi R, Zindy F, Roussel MF and Cleveland JL: C-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. J Biol Chem 276: 29994-30001, 2001.
31. Xiao X, Sidorov IA, Gee J, Lempicki RA and Dimitrov DS: Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol 79: 108-117, 2005. (Pubitemid 41262492)